FY24 net profit rose 11.2% to W2.1tn, driven by health insurance and investment gains, with DPS up 21.6%. Capital adequacy remains strong, and the company targets further growth in health products and digital channels.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.